当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › Neurotoxicity Research杂志
Neurotoxicity Research
基本信息
期刊名称 Neurotoxicity Research
NEUROTOX RES
期刊ISSN 1029-8428
期刊官方网站 https://www.springer.com/12640
是否OA No
出版商 Springer New York
出版周期 Bimonthly
文章处理费 登录后查看
始发年份 1999
年文章数 47
影响因子 2.9(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学3区 NEUROSCIENCES 神经科学3区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 7.7 0.789 0.734
Pharmacology, Toxicology and Pharmaceutics
Toxicology
20/133 85%
Neuroscience
General Neuroscience
27/113 76%
补充信息
自引率 3.4%
H-index 65
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1029-8428%5BISSN%5D
投稿指南
期刊投稿网址 https://www.editorialmanager.com/NTRE
收稿范围
Neurotoxicity Research is an international, interdisciplinary broad-based journal for reporting both basic and clinical research on classical neurotoxicity effects and mechanisms associated with neurodegeneration, necrosis, neuronal apoptosis, nerve regeneration, neurotrophin mechanisms, and topics related to these themes.

Published papers have focused on:

NEURODEGENERATION and INJURY
Neuropathologies
Neuronal apoptosis
Neuronal necrosis
Neural death processes (anatomical, histochemical, neurochemical)
Neurodegenerative Disorders
Neural Effects of Substances of Abuse

NERVE REGENERATION and RESPONSES TO INJURY
Neural Adaptations
Neurotrophin mechanisms and actions

NEURO(CYTO)TOXICITY PROCESSES and NEUROPROTECTION
Excitatory amino acids
Neurotoxins, endogenous and synthetic
Reactive oxygen (nitrogen) species
Neuroprotection by endogenous and exogenous agents
收录体裁
投稿指南 https://link.springer.com/journal/12640/submission-guidelines
投稿模板
参考文献格式
编辑信息

EDITOR-IN-CHIEF

Richard M. KostrzewaDepartment of Biomedical Sciences, Quillen College of Medicine, East Tennessee State Univ., Johnson City TN, USA

ASSOCIATE EDITORS

Mario Herrera-MarschitzProgram of Molecular and Clinical Pharmacology, University of Chile, Santiago, Chile

Xin-Fu ZhouSchool of Pharmacy and Medical Sciences, Faculty of Health Sciences, University of South Australia, Adelaide, Australia

EDITORIAL BOARD

Lucyna Antkiewicz-MichalukDepartment of Neurochemistry, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland

Marta C. AntonelliInstituto de Biología Celular y Neurociencias "Prof. E. De Robertis", CONICET-UBA, Universidad de Buenos Aires, Argentina

Trevor ArcherDepartment of Psychology, Universities of Göteborg and Kalmar, Sweden

Masato AsanumaDepartment of Brain Sciences, Okayama University, Graduate School of Medicine, Dentistry & Pharmaceutical Sciences, Japan

Rommy von BernhardiDepartamento de Neurología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile

Rryszard BrusDepartment of Nursing, High School of Strategic Planning, Dabrowa Gornicza, Poland

Vladimir L. BuchmanSchool of Biosciences, Cardiff University, Cardiff, UK

Anna R. CartaDepartment of Biomedical Sciences, University of Cagliari, Italy

Jean Lud CadetMolecular Neuropsychiatry Research Branch, DHHS/NIH/NIDA Intramural Research Program, NIH, Baltimore, MD, USA

Sandra CeccatelliDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden

Michael A. CollinsDepartment of Molecular Pharmacology & Therapeutics, Loyola University, Chicago, Stritch School of Medicine, Maywood, IL, USA

Cynthia A. CrawfordDepartment of Psychology, California State University, San Bernardino, CA, USA

Wojciech DanyszMerz Pharmaceuticals GmbH, Frankfurt/Main, Germany

Elaine Del-BelDepartment of Morphology Physiology & Basic Pathology, Dental School of Ribeirão Preto, University of São Paulo, Brazil

Malgorzata FilipLaboratory of Drug Addiction Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland

Fabio FumagalliDipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milano, Italy

Raul GainetdinovDepartment of Neuroscience & Brain Technologies, Istituto Italiano di Tecnologia, Genova, Italy; Skolkovo Institute of Science & Technology, Moscow Region, Russia; Institute of Translational Biomedicine, St. Petersburg State University, Russia

Krystyna Gołembiowska, Department of Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland

Gilles GuilleminNeuropharmacology Group, MND & Neurodegenerative Diseases Research Center, Macquarie University, Sydney, Australia

G. Jean HarryNeurotoxicology Group, National Toxicology Program Laboratory, NIEHS/NIH, Research Triangle Park, NC, USA

Maria-Trinidad Herrero Ezquerro, Clinical & experimental Neuroscience, Department of Human Anatomy & Psychobiology, University of Murcia, Spain
Danuta JantasDepartment of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland

Kristen A. KeefeInterdepartmental Program in Neuroscience, University of Utah, Salt Lake City, UT, USA

Władysław Lasoń, Department of Experimental Neuroendocrinology, Director – Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland

J. William LangstonParkinson's Institute and Clinical Center, Sunnyvale, CA, USA

Giovanni LaviolaDepartment of Cell Biology and Neuroscience, Section of Behavioural Neuroscience, Istituto Superiore di Sanità Roma, Italy

Italo MocchettiDepartment of Neuroscience, Laboratory of Preclinical Neurobiology, Georgetown University Medical Center, Washington, DC, USA

Rosario MoratallaInstituto Cajal, CSIC and 5CIBERNED, Instituto de Salud Carlos III, Madrid, Spain

Micaela MorelliDeparment of Biomedical Sciences, Section of Neuropsychopharmacology, University of Cagliari; Institute of Neuroscience, Cagliari, Italy

Hiroku NawaDepartment of Molecular Biology, Brain Research Institute, Niigata University, Niigata, Japan

Tomas PalomoPsychiatry Deparment, Laboratory of Neurosciences, Instituto de Investigación Sanitaria del Hospital Universitario, Madrid, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), ISCIII, Spain

Rui D. PredigerDepartamento de Farmacologia, Centro de Ciências Biológicas, Universidade Federal de Santa Catarina, Florianópolis, Brazil

Rita Raisman-VozariINSERM, Thérapeutique Expérimentale de la Neurodégénérescence, Hôpital de la Salpetrière -ICM , Paris, France

Dora ReglodiDepartment of Anatomy, MTA-PTE PACAP Lendulet Research Group, Medical School, University of Pecs, Pecs, Hungary

Peter RiedererCenter of Mental Health, Clinic and Policlinic for Psychiatry, Psychosomatics and Psychotherapy, University of Würzburg, Germany

Richard SalviCenter for Hearing and Deafness, State University of New York at Buffalo, Buffalo, NY, USA

Abel Santamaria, Head – Lab de Aminoácidos Excitadores, Inst Nacional de Nueorlogía y Neurocirurgía Insurgentes, Mexico City, Mexico

Arne SchousboeDepartment of Drug Design and Pharmacology, Faculty of Health and Medicine, University of Copenhagen, Denmark

Juan Segura-AguilarDepartment of Molecular and Clinical Pharmacology, Faculty of Medicine, University of Chile, Santiago, Chile

Nadia StefanovaDivision of Neurobiology, Department of Neurology, Innsbruck Medical University, Innsbruck, Austria

Harry W.M. Steinbusch, Department of Cellular Neuroscience, Faculty of Health, Medicine & Life Sciences, Maastricht University, Netherlands

Yousef TizabiDepartment of Pharmacology, Howard University College of Medicine, Washington, DC, USA

Moacir WajnerServiço de Genética Médica, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil

Yanjiang WangDepartment of Neurology & Centre for Clinical Neuroscience, Third Military Medical University, Chongqing, China

Orly WeinrebEve Topf Center, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

Xingshun XuJiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases and Department of Neurology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China

Luigi ZeccaInstitute of Biomedical Technologies, National Research Council of Italy, Segrate, Milan, Italy


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug